The global ankylosing spondylitis drugs market is forecast to reach USD 8,413.0 Million by 2028, according to a new report by Reports and Data.

Ankylosing spondylitis (AS) could be a chronic condition that has no permanent cure. It is outlined as an inflammatory disease that leads to a number of the small bones within the spine (vertebrae) fusing over time.